Related references
Note: Only part of the references are listed.Disposition of Astragaloside IV via Enterohepatic Circulation Is Affected by the Activity of the Intestinal Microbiome
Yi Jin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)
UPLC-Q-TOF/MS-based screening and identification of two major bioactive components and their metabolites in normal and CKD rat plasma, urine and feces after oral administration of Rehmannia glutinosa Libosch extract
Jin-hua Tao et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2015)
Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium
Yan Zhao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
TERT promoter mutations and telomerase reactivation in urothelial cancer
Sumit Borah et al.
SCIENCE (2015)
Cycloastragenol, a triterpene aglycone derived from Radix astragali, suppresses the accumulation of cytoplasmic lipid droplet in 3T3-L1 adipocytes
Shifeng Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Profiling the Metabolism of Astragaloside IV by Ultra Performance Liquid Chromatography Coupled with Quadrupole/Time-of-Flight Mass Spectrometry
Xu-Dong Cheng et al.
MOLECULES (2014)
Cycloastragenol Is a Potent Telomerase Activator in Neuronal Cells: Implications for Depression Management
Fanny C.F. Ip et al.
NEUROSIGNALS (2014)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: TRANSPORTERS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Possibilities and effects of telomerase activation
N. A. Kovalenko et al.
MOLECULAR BIOLOGY (2013)
A Novel Telomerase Activator Suppresses Lung Damage in a Murine Model of Idiopathic Pulmonary Fibrosis
Claude Jourdan Le Saux et al.
PLOS ONE (2013)
Bioactivity and Bioavailability of Ginsenosides are Dependent on the Glycosidase Activities of the A/J Mouse Intestinal Microbiome Defined by Pyrosequencing
Tao Niu et al.
PHARMACEUTICAL RESEARCH (2013)
Pharmacokinetic Evidence on the Contribution of Intestinal Bacterial Conversion to Beneficial Effects of Astragaloside IV, a Marker Compound of Astragali Radix, in Traditional Oral Use of the Herb
Rui-Na Zhou et al.
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Oral bioavailability and gender-related pharmacokinetics of celastrol following administration of pure celastrol and its related tablets in rats
Jun Zhang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
Molecular regulation of telomerase activity in aging
Craig Nicholls et al.
PROTEIN & CELL (2011)
In vitro Intestinal Absorption and First-pass Intestinal and Hepatic Metabolism of Cycloastragenol, a Potent Small Molecule Telomerase Activator
Jing Zhu et al.
DRUG METABOLISM AND PHARMACOKINETICS (2010)
Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali
YC Gu et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2004)
Share Paper
